AVITA Medical, Inc. (RCEL) Net Cash Flow (2019 - 2025)

AVITA Medical (RCEL) has reported Net Cash Flow for 7 consecutive years, with -$5.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 13.93% year-over-year to -$5.2 million; the trailing twelve-month figure through Dec 2025 stood at -$3.8 million (up 52.52% YoY), and the FY2025 full-year result was -$3.8 million, up 52.52% from the prior year.
• Net Cash Flow eased to -$5.2 million in Q4 2025 per RCEL's latest filing, from $3.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $55.1 million in Q1 2021 and bottomed at -$64.0 million in Q4 2021.
• Historically, Net Cash Flow has averaged -$3.4 million across 5 years, with a median of -$53000.0 in 2022.
• The sharpest annual moves came in 2021 and 2023: Net Cash Flow surged 822.38% in 2021, then plunged 4633.94% in 2023.
• Over 5 years, Net Cash Flow stood at -$64.0 million in 2021, then soared by 99.05% to -$607000.0 in 2022, then slumped by 4633.94% to -$28.7 million in 2023, then jumped by 84.17% to -$4.6 million in 2024, then declined by 13.93% to -$5.2 million in 2025.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$5.2 million, $3.2 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.